174 related articles for article (PubMed ID: 1847743)
1. Transformation of rat bladder epithelial cells by introduction of a single oncogene.
Mann AM; Stevenson M; Masui T; Borgeson CD; Cohen SM
Oncogene Res; 1991; 6(1):65-72. PubMed ID: 1847743
[TBL] [Abstract][Full Text] [Related]
2. Invasiveness and metastatic capability of rat fibroblast-like cells before and after transfection with immortalizing and transforming genes.
Van Roy FM; Messiaen L; Liebaut G; Gao J; Dragonetti CH; Fiers WC; Mareel MM
Cancer Res; 1986 Sep; 46(9):4787-95. PubMed ID: 3015398
[TBL] [Abstract][Full Text] [Related]
3. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
[TBL] [Abstract][Full Text] [Related]
4. Rapid induction of an experimental metastatic phenotype in first passage rat embryo cells by cotransfection of EJ c-Ha-ras and c-myc oncogenes.
Storer RD; Allen HL; Kraynak AR; Bradley MO
Oncogene; 1988 Feb; 2(2):141-7. PubMed ID: 3285293
[TBL] [Abstract][Full Text] [Related]
5. Oncogene-mediated transformation of fetal rat colon in vitro.
Pories S; Jaros K; Steele G; Pauley A; Summerhayes IC
Oncogene; 1992 May; 7(5):885-93. PubMed ID: 1373876
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
7. [The effect of Ha-ras oncogene on cells immortalized by the gene for polyomavirus large T-antigen].
Komissarova EV; Spitkovskiĭ DD; Mazurenko NN; Tatosian AG
Mol Gen Mikrobiol Virusol; 1990 Feb; (2):19-22. PubMed ID: 2185418
[TBL] [Abstract][Full Text] [Related]
8. Evidence for multiple steps in neoplastic transformation of normal and preneoplastic Syrian hamster embryo cells following transfection with Harvey murine sarcoma virus oncogene (v-Ha-ras).
Thomassen DG; Gilmer TM; Annab LA; Barrett JC
Cancer Res; 1985 Feb; 45(2):726-32. PubMed ID: 2981612
[TBL] [Abstract][Full Text] [Related]
9. Tumor rejection antigens on BALB3T3 cells transformed by activated oncogenes.
Torigoe T; Sato N; Takashima T; Cho JM; Tsuboi N; Qi WM; Hara I; Wada Y; Takahashi N; Kikuchi K
J Immunol; 1991 Nov; 147(9):3251-8. PubMed ID: 1919013
[TBL] [Abstract][Full Text] [Related]
10. N-methyl-N-nitrosourea-induced transformation of rat urothelial cells in vitro is not mediated by activation of ras oncogenes.
Knowles MA; Eydmann ME; Proctor A; Padua RA; Roberts J
Oncogene; 1987 May; 1(2):143-8. PubMed ID: 3325878
[TBL] [Abstract][Full Text] [Related]
11. Pathogenicity of retroviruses containing either the normal human c-Ha-ras1 gene or its mutated form derived from the bladder carcinoma EJ/T24 cell line.
Chang EH; Morgan PL; Lee EJ; Pirollo KF; White EA; Patrick DH; Tsichlis PN
J Exp Pathol; 1985; 2(3):177-89. PubMed ID: 3842394
[TBL] [Abstract][Full Text] [Related]
12. Role of oncogenes and tumour suppressor genes in human lung carcinogenesis.
Harris CC; Reddel R; Pfeifer A; Iman D; McMenamin M; Trump BF; Weston A
IARC Sci Publ; 1991; (105):294-304. PubMed ID: 1855868
[TBL] [Abstract][Full Text] [Related]
13. A nonkaryophilic T antigen of SV40 can either immortalize or transform rodent cells, and cooperates better with cytoplasmic than with nuclear oncoproteins.
Fischer-Fantuzzi L; Vesco C
Oncogene Res; 1987 Aug; 1(3):229-42. PubMed ID: 2835734
[TBL] [Abstract][Full Text] [Related]
14. Oncogene transformation frequency of nonsenescent SFME cells is increased by c-myc.
Rawson C; Shirahata S; Collodi P; Natsuno T; Barnes D
Oncogene; 1991 Mar; 6(3):487-9. PubMed ID: 2011405
[TBL] [Abstract][Full Text] [Related]
15. [The mouse ovarian surface epithelium cells (MOSE) transformation induced by c-myc/K-ras in].
Yao DS; Li L; Garson K; Vanderhyden BC
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):881-5. PubMed ID: 17533735
[TBL] [Abstract][Full Text] [Related]
16. Oncogene complementation in fetal brain transplants.
Wiestler OD; Aguzzi A; Schneemann M; Eibl R; von Deimling A; Kleihues P
Cancer Res; 1992 Jul; 52(13):3760-7. PubMed ID: 1319831
[TBL] [Abstract][Full Text] [Related]
17. Transforming and oncogenic potential of activated c-Ha-ras in three immortalized human breast epithelial cell lines.
Wang B; Soule HD; Miller FR
Anticancer Res; 1997; 17(6D):4387-94. PubMed ID: 9494538
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
Spandidos DA
Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
[TBL] [Abstract][Full Text] [Related]
19. Expression of hepatocyte and oval cell antigens in hepatocellular carcinomas produced by oncogene-transfected liver epithelial cells.
Goyette M; Faris R; Braun L; Hixson D; Fausto N
Cancer Res; 1990 Aug; 50(15):4809-17. PubMed ID: 2196118
[TBL] [Abstract][Full Text] [Related]
20. Introduction of a Ha-ras oncogene into rat liver epithelial cells and parenchymal hepatocytes confers resistance to the growth inhibitory effects of TGF-beta.
Houck KA; Michalopoulos GK; Strom SC
Oncogene; 1989 Jan; 4(1):19-25. PubMed ID: 2783773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
